Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial.
McGiffin DC, Kure CE, Macdonald PS, Jansz PC, Emmanuel S, Marasco SF, Doi A, Merry C, Larbalestier R, Shah A, Geldenhuys A, Sibal AK, Wasywich CA, Mathew J, Paul E, Cheshire C, Leet A, Hare JL, Graham S, Fraser JF, Kaye DM.
McGiffin DC, et al. Among authors: hare jl.
J Heart Lung Transplant. 2024 Mar;43(3):485-495. doi: 10.1016/j.healun.2023.10.020. Epub 2023 Oct 31.
J Heart Lung Transplant. 2024.
PMID: 37918701
Clinical Trial.